Lack of ErbB-2 Oncogene Product Overexpression in Soft Tissue Sarcomas

By Merimsky Ofer   Issakov Josephine   Schwartz Ignat   Dadia Shlomo   Kollender Yehuda   Bickels Jacob   Inbar Moshe   Meller Isaac  

Acta Oncologica, Vol. 41, Iss. 4, 2002-06 ,pp. : 366-368

Informa Healthcare

Access to resources Recommend Favorite

Dermatologic adverse events associated with afatinib: an oral ErbB family blocker

By Lacouture Mario E   Schadendorf Dirk   Chu Chia-Yu   Uttenreuther-Fischer Martina   Stammberger Uz   O'Brien Dennis   Hauschild Axel  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 721-728

Informa Healthcare

Access to resources Recommend Favorite

Diarrhea associated with afatinib: an oral ErbB family blocker

By Yang James Chih-Hsin   Reguart Noemi   Barinoff Jana   Köhler Jens   Uttenreuther-Fischer Martina   Stammberger Uz   O'Brien Dennis   Wolf Jürgen   Cohen Ezra EW  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 6, 2013-06 ,pp. : 729-736

Informa Healthcare

Access to resources Recommend Favorite

Autocrine Signalling Through erbB Receptors Promotes Constitutive Activation of Protein Kinase B/Akt in Breast Cancer Cell Lines

By Nicholson K.M.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 2, 2003-09 ,pp. : 117-128

Springer Publishing Company

Access to resources Recommend Favorite

Correlation Analysis of HOX, ErbB and IGFBP Family Gene Expression in Ovarian Cancer

By Bahrani-Mostafavi Zahra   Tickle Timothy   Zhang Jian   Bennett Kristen   Vachris Judith   Spencer Melanie   Mostafavi M. Taghi   Tait David  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 990-998

Informa Healthcare

Access to resources Recommend Favorite